Insider Stock Sales in the Healthcare Sector: LLY, SYK, HUM, BSX, WPI, VAR

Wall St. Watchdog reveals information about insiders who are bearish on these stocks in the Healthcare sector for the week ending November 18th, 2011.

  • Bryce D Carmine who is EVP and Pres, Lilly Bio-Meds at Eli Lilly & Co. (NYSE:LLY), sold 5,700 shares on Nov 11 at $37.55 per share for a total value of $214,035. The shares recently traded at $36.34, down $1.51, or 3.99% since the insider sale. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. Get the most recent company news and stock data here >>
  • Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Nov 14 at $49.49 per share for a total value of $445,445. The shares recently traded at $46.23, down $2.71, or 5.54% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>
  • Bruce J Goodman who is Sr. VP at Humana Inc. (NYSE:HUM), sold 33,948 shares on Nov 11 at $87.88 per share for a total value of $2,983,448. The shares recently traded at $83.94, down $4.17, or 4.73% since the insider sale. About the company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals. Get the most recent company news and stock data here >>
  • Nelda J Connors who is Director at Boston Scientific Corporation (NYSE:BSX), sold 2,500 shares on Nov 14 at $5.84 per share for a total value of $14,600. The shares recently traded at $5.30, down $0.54, or 9.25% since the insider sale. About the company: Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation. Get the most recent company news and stock data here >>
  • Andrew L Turner who is Non-Executive Chairman at Watson Pharmaceuticals Inc. (NYSE:WPI), sold 10,000 shares on Nov 15 at $65.76 per share for a total value of $657,600. The shares recently traded at $64.93, down $0.9, or 1.37% since the insider sale. About the company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products. Get the most recent company news and stock data here >>
  • Ruediger Naumann-Etienne who is Director at Varian Medical Systems Inc. (NYSE:VAR), sold 1,901 shares on Nov 15 at $60.75 per share for a total value of $115,490. The shares recently traded at $57.29, down $3.31, or 5.46% since the insider sale. About the company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products. Get the most recent company news and stock data here >>
  • Jacques Tapiero who is SVP&Pres., Emerging Markets at Eli Lilly & Co. (NYSE:LLY), sold 5,000 shares on Nov 18 at $36.88 per share for a total value of $184,400. The shares recently traded at $36.34, down $0.55, or 1.49% since the insider sale. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet